Agarwal, S., and S. Mehta. “Food and Drug Administration Gives Breakthrough: Sanctioning of Rezdiffra for Non-Alcoholic Steatohepatitis”. International Journal of Advances in Medicine, vol. 12, no. 1, Dec. 2024, pp. 155-, doi:10.18203/2349-3933.ijam20243826.